Table 1 Characteristics of the enrolled eyes
From: Visual acuity improvement after phacoemulsification cataract surgery in patients aged ≥90 years
Group 1 (≥90 years old) | Group 2 (< 80 years old) | P Value | |
|---|---|---|---|
Eyes (patients) | 138 | 152 | |
Age, Mean ± SD (range) | 92.3 ± 2.3 | 72.3 ± 5.6 | < 0.001* |
Male/female | 40/98 | 54/98 | 0.259 |
Systemic comorbidities | |||
DM, patients (%) | 16(11.6%) | 30(19.7%) | 0.0761 |
HT, patients (%) | 92(66.7%) | 67(44.1%) | < 0.001* |
LOCS III Grading (Nuclear cataract) | < 0.001* | ||
1 | 0 | 0 | |
2 | 9 | 33 | |
3 | 63 | 88 | |
4 | 49 | 24 | |
5 | 10 | 4 | |
6 | 7 | 3 | |
LOCS III Grading (Cortical cataract) | 0.164 | ||
1 | 27 | 12 | |
2 | 58 | 77 | |
3 | 45 | 57 | |
4 | 8 | 6 | |
LOCS III Grading (Posterior cataract) | 0.192 | ||
1 | 100 | 100 | |
2 | 13 | 14 | |
3 | 14 | 21 | |
4 | 8 | 15 | |
5 | 3 | 2 | |
Preoperative BCVA, logMAR ± SD | 0.70 ± 0.60 | 0.46 ± 0.50 | < 0.001* |
Postoperative BCVA, logMAR ± SD | |||
1 month | 0.11 ± 0.13 | −0.01 ± 0.12 | < 0.001* |
3 months | 0.11 ± 0.12 | − 0.01 ± 0.11 | < 0.001* |